Elan, Abbott Drop Teva Patent Suit Over Tricor
Elan Pharma International Ltd. and a subsidiary of Abbott Laboratories on Thursday dropped a New Jersey suit accusing Teva Pharmaceuticals USA Inc. of infringing three patents for cholesterol drug Tricor....To view the full article, register now.
Already a subscriber? Click here to view full article